This brand name is authorized in Estonia, France, Hong Kong, Turkey
The drug TRH contains one active pharmaceutical ingredient (API):
|
1
Protirelin
UNII 5Y5F15120W - PROTIRELIN
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CJ02 | Protirelin | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CJ Tests for thyreoidea function |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1116739, 1401242 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68393033 |
| Country: HK | Department of Health Drug Office | Identifier(s): 40059 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8697621750180 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
